Callan Family Office LLC Takes $1.15 Million Position in Mettler-Toledo International, Inc. $MTD

Key Points

• Callan Family Office initiated a $1.15 million position in Mettler-Toledo International during the second quarter by purchasing 902 shares. Institutional investors collectively own 95.07% of the company.
• Insiders sold 3,312 shares worth approximately $4.75 million over the past quarter, including significant ownership reductions by Director Thomas P. Salice and insider Gerry Keller.
• Mettler-Toledo exceeded quarterly EPS expectations, reporting $11.46 versus the $10.78 consensus, while revenue rose 4.5% year over year to $1.03 billion. Analysts maintain a consensus “Hold” rating with a $1,461.27 price target.

Callan Family Office LLC bought a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 902 shares of the medical instruments supplier's stock, valued at approximately $1,152,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Keating Financial Advisory Services Inc. acquired a new position in Mettler-Toledo International in the 2nd quarter valued at about $84,000. OneAscent Investment Solutions LLC bought a new position in Mettler-Toledo International in the 2nd quarter valued at about $262,000. Patron Partners LLC acquired a new stake in Mettler-Toledo International during the second quarter worth approximately $1,027,000. OneAscent Family Office LLC bought a new stake in shares of Mettler-Toledo International during the second quarter worth approximately $216,000. Finally, Allworth Financial LP bought a new stake in shares of Mettler-Toledo International during the second quarter worth approximately $290,000. Institutional investors own 95.07% of the company's stock.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Thomas P. Salice sold 417 shares of the stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $1,440.41, for a total transaction of $600,650.97. Following the sale, the director directly owned 292 shares in the company, valued at $420,599.72. This represents a 58.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Gerry Keller sold 240 shares of the firm's stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total transaction of $342,513.60. Following the completion of the transaction, the insider directly owned 259 shares in the company, valued at approximately $369,629.26. This represents a 48.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 3,312 shares of company stock valued at $4,750,362 over the last quarter. 0.71% of the stock is owned by company insiders.

Analysts Set New Price Targets

MTD has been the topic of a number of recent research reports. Wolfe Research assumed coverage on Mettler-Toledo International in a research note on Tuesday, June 2nd. They set a "peer perform" rating on the stock. Citigroup reduced their price target on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a "buy" rating for the company in a research note on Friday, May 8th. Barclays upped their price objective on Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the company an "overweight" rating in a report on Monday, August 3rd. Wall Street Zen downgraded Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Saturday, May 16th. Finally, Morgan Stanley boosted their target price on shares of Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the company an "equal weight" rating in a research report on Tuesday, August 4th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $1,461.27.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,399.02 on Tuesday. The stock has a market capitalization of $28.04 billion, a PE ratio of 31.49, a P/E/G ratio of 2.87 and a beta of 1.23. The company has a debt-to-equity ratio of 159.45, a current ratio of 1.12 and a quick ratio of 0.78. The business has a fifty day moving average price of $1,324.55 and a two-hundred day moving average price of $1,273.73. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.78 by $0.68. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period in the prior year, the firm posted $10.09 EPS. Mettler-Toledo International's quarterly revenue was up 4.5% on a year-over-year basis. As a group, equities analysts predict that Mettler-Toledo International, Inc. will post 47.35 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company's product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source